Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Cancer Metastatic × regorafenib × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 29 Carcinoma, Hepatocellular 12 Glioblastoma 5 Colonic Neoplasms 5 Sarcoma, Ewing 3 Rectal Neoplasms 3 Osteosarcoma 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Leukemia, Myeloid, Acute 2 Gastrointestinal Stromal Tumors 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Chondrosarcoma 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Spinocerebellar Degenerations 1 Solid Malignant Tumors 1 Small Cell Lung Carcinoma 1 Recurrence 1 Patient Compliance 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neoplasms 1 Myelodysplastic Syndromes 1

Interventions

Bevacizumab 8 Capecitabine 4 Fluorouracil 3 Cetuximab 3 trifluridine tipiracil drug combination 2 Nivolumab 2 sintilimab 1 regorafenib 1 irinotecan sucrosofate 1 folfirinox 1 balstilimab 1 anisodamine 1 Vemurafenib 1 Tomography, X-Ray Computed 1 Panitumumab 1 Oxaliplatin 1 Liver Transplantation 1 Leucovorin 1 Irinotecan 1 Ipilimumab 1 Folfox protocol 1 Doxorubicin 1 Dexamethasone 1 Decitabine 1 2-(phenylmethyl)-1-naphthol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04874207 2025-08-08

RePERSO

Rennes University Hospital

Phase 4 Completed

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡